Cargando...
Etidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women
BACKGROUND: Osteoporosis is an abnormal reduction in bone mass and bone deterioration leading to increased fracture risk. Etidronate belongs to the bisphosphonate class of drugs which act to inhibit bone resorption by interfering with the activity of osteoclasts. OBJECTIVES: To assess the efficacy o...
Guardado en:
| Publicado en: | Cochrane Database Syst Rev |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
John Wiley & Sons, Ltd
2008
|
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6999803/ https://ncbi.nlm.nih.gov/pubmed/18254018 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD003376.pub3 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|